BGIM
CLB icon

Brandywine Global Investment Management’s Core Laboratories CLB Stock Holding History

Brandywine Global Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-96,872
Closed -$1.92M – 741
2022
Q2 		$1.92M Sell
96,872
-10,590
-10% -$281K 0.02% 544
2022
Q1 		$3.4M Sell
107,462
-59
-0.1% -$1.65K 0.02% 457
2021
Q4 		$2.4M Sell
107,521
-14,805
-12% -$386K 0.02% 506
2021
Q3 		$3.4M Sell
122,326
-1,139
-0.9% -$34.7K 0.03% 459
2021
Q2 		$4.81M Sell
123,465
-6,917
-5% -$248K 0.04% 423
2021
Q1 		$3.75M Sell
130,382
-1,022
-0.8% -$34.9K 0.03% 452
2020
Q4 		$3.48M Sell
131,404
-13,517
-9% -$276K 0.03% 428
2020
Q3 		$2.21M Buy
144,921
+12,740
+10% +$267K 0.02% 447
2020
Q2 		$2.69M Buy
+132,181
New +$2.37M 0.03% 421
2014
Q3 		– Sell
-20
Closed -$4K – 967
2014
Q2 		$4K Hold
20
– – ﹤0.01% 940
2014
Q1 		$4K Hold
20
– – ﹤0.01% 910
2013
Q4 		$4K Buy
+20
New +$3.72K ﹤0.01% 950

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Brandywine Global Investment Management's CLB Position: Q3 2022 in Review

Brandywine Global Investment Management sold out of Core Laboratories (CLB) in Q3 2022, closing a stake of 96,872 shares — an estimated $1.92M sold.

Brandywine Global Investment Management first reported a position in CLB in Q4 2013 and held it in 12 quarters. The position peaked at $4.81M in Q2 2021. 162 funds tracked by Wall St. Rank hold CLB as of Q3 2022.

  • Brandywine Global Investment Management reported no remaining Core Laboratories position as of Q3 2022 after selling out during the quarter.
  • Brandywine Global Investment Management sold 96,872 Core Laboratories shares in Q3 2022, an estimated $1.92M.
  • Brandywine Global Investment Management first reported a position in Core Laboratories in Q4 2013 and held it in 12 quarters.
  • Brandywine Global Investment Management's Core Laboratories position peaked at $4.81M in Q2 2021.
  • 162 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2022.

Based on Brandywine Global Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.